biden fails

Falls and cognitive decline in men with prostate cancer (CRPC) may be influenced by factors such as androgen deprivation therapy (ADT) and neurohormonal agents (NHAs)12345. Clinicians should monitor cognitive function in patients with advanced prostate cancer, especially those treated with ADT25 https://www.hematologyandoncology.net/archives/november-2019/assessing-the-risk-of-cognitive-impairment-among-men-with-prostate-cancer/